组织工程修复软骨缺损的研究进展
张治金1 曾林如2 朱芳兵3 郭林4
1.杭州市萧山区中医院十一病区 手外科二,浙江杭州 311201;
2.杭州市萧山区中医院足踝外科,浙江杭州 311201;
3.杭州市萧山区中医院运动医学科,浙江杭州 311201;
4.大连大学附属中山医院关节外科,辽宁大连 116001
Study progress of tissue-engineered cartilage in repairing cartilage defect
ZHANG Zhijin1 ZENG Linru2 ZHU Fangbing3 GUO Lin4
1.Eleven Ward Two Department of Hand Surgery, Xiaoshan District Hospital of Traditional Chinese Medicine of Hangzhou City, Zhejiang Province, Hangzhou 311201, China;
2.Department of Ankle Surgery, Xiaoshan District Hospital of Traditional Chinese Medicine of Hangzhou City, Zhejiang Province, Hangzhou 311201, China; 3.Department of Sports Medicine, Xiaoshan District Hospital of Traditional Chinese Medicine of Hangzhou City, Zhejiang Province, Hangzhou 311201, China; 4.Department of Joint Surgery, Zhongshan Hospital Affiliated to Dalian University, Liaoning Province, Dalian 116001, China
摘要 关节软骨缺损所带来的疼痛及关节活动障碍严重影响了患者的生活质量,组织工程技术应用于软骨缺损的修复成为研究的热点,为其治疗提供了新的思路。本文就种子细胞的要求、来源以及培养方法,生物支架的要求及类型,细胞生长调节因子进行综述,总结组织工程修复软骨缺损的研究进展。
关键词 :
软骨缺损 ,
组织工程 ,
种子细胞 ,
支架 ,
细胞因子
Abstract :The pain and joint movement disorder caused by articular cartilage defects have seriously affected the quality of life of patients. The application of tissue engineering technology in the repair of cartilage defects has become a hot topic in research, which provides a new idea for its treatment. In this paper, we review the research progress of tissue engineering to repair cartilage defects on the basis of the requirements, sources and methods of seed cells, the requirements and types of biological scaffold, and the regulation of cell growth factors.
Key words :
Cartilage defect
Tissue engineering
Seeding cells
Support
Cytokines
基金资助: 浙江省杭州市科技发展计划项目(20130733 Q43)。
作者简介 : 张治金(1981.12-),男,硕士;研究方向:手足外科组织工程。
[1] Sittinger M,Bujia J,Rotter N,et al. Tissue engineering and autologous transplant formation:practical approaches with resorbable biomaterials and new cell culture techniques [J]. Biomaterials,1996,17(3):237.
[2] Marijnissen WJ,van Osch GJ,Aigner J,et al. Alginate as a chondrocyte-delivery substance in combination with a non-woven scaffold for cartilage tissue engineering [J]. Biomaterials,2002,23(6):1511.
[3] Gobbi A,Nunag P,Malinowski K. Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes [J]. Knee Surg Sports Traumatol Arthrosc,2005,13(3):213-221.
[4] Widuchowski W,Widuchowski J,Trzaska T. Articular cartilage defects:study of 25,124 knee arthroscopies [J]. Knee,2007,14(3):177-182.
[5] Gross AE,Agnidis Z,Hutchison CR. Osteochondral defects of the talus treated with fresh osteochondral allograft transplantation [J]. Foot Ankle Int,2001,22(5):385.
[6] Langer R. Tissue engineering [J]. Science,2000,260(5110):920-926.
[7] 丛波,张仲文.软骨组织工程种子细胞源的研究进展[J].中华灾害救援医学,2016,4(6):341-344.
[8] Angele P,Yoo JU,Smith C,et al. Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro [J]. J Orthop Res,2003,21(3):451-457.
[9] Worster AA,Brower-Toland BD,Fortier LA,et al. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix [J]. J Orthop Res,2001,19(4):738.
[10] Campbell JJ,Lee DA,Bader DL. Dynamic compressive strain influences chondrogenic gene expression in human mesenchymal stem cells [J]. Biorheology,2006,43(3-4):455-470.
[11] 张仲文,侯世科,杨造成,等.基质诱导的自体软骨细胞移植术修复膝关节软骨缺损10例术后2年的随访[J].中华关节外科杂志:电子版,2010,4(6):734-741.
[12] Koga H,Engebretsen L,Brinchmann JE,et al. Mesenchymal stem cell-based therapy for cartilage repair:a review [J]. Knee Surg Sports Traumatol Arthrosc,2009,17(11):1289-1297.
[13] Lu FZ,Fujino M,Kitazawa Y,et al. Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood [J]. J Laboratory Clin Med,2005,146(5):271-278.
[14] Grande DA,Mason J,Light E,et al. Stem cells as platforms for delivery of genes to enhance cartilage repair [J]. J Bone Joint Surg,2003,85(1):111-116.
[15] 陈佳琦,陈慧敏.间充质干细胞的研究现状与应用前景[J].北京生物医学工程,2015,34(4):435-438.
[16] Abdallah BM,Kassem M. Human mesenchymal stem cells:from basic biology to clinical applications [J]. Gene Ther,2008,15(2):109-116.
[17] Kuroda R,Usas A,Kubo S,et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells [J]. Arthrit Rheumat,2006,54(2):433-442.
[18] 李丹,周广东,刘涓,等.骨髓间充质干细胞体外构建组织工程化半月板[J].组织工程与重建外科杂志,2013,9(5):251-255.
[19] Murphy JM,Dixon K,Beck S,et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis [J]. Arthrit Rheumat,2002,46(3):704-713.
[20] 孙鹏浩.软骨细胞和骨髓间充质干细胞体外共培养的成瘤危险性的研究[D].南京:东南大学,2014.
[21] Estes BT,Diekman BO,Gimble JM,et al. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype [J]. Nat Protocol,2010,5(7):1294-1311.
[22] Winter A,Breit S,Parsch D,et al. Cartilage-like gene expression in differentiated human stem cell spheroids:a comparison of bone marrow–derived and adipose tissue-derived stromal cells [J]. Arthrit Rheumatol,2003, 48(2):418-429.
[23] Wakitani S,Aoki H,Harada Y,et al. Embryonic stem cells form articular cartilage,not teratomas,in osteochondral defects of rat joints [J]. Cell Transplant,2004,13(4):331-336.
[24] Kramer J,B?觟hrnsen F,Schlenke P,et al. Stem cell-derived chondrocytes for regenerative medicine [J]. Transplant Proceed,2006,38(3):762-765.
[25] Ringe J,Kaps C,Burmester GR,et al. Stem cells for regenerative medicine:advances in the engineering of tissues and organs [J]. Sci Nat,2002,89(8):338-351.
[26] Lee CR,Grodzinsky AJ,Spector M. Biosynthetic response of passaged chondrocytes in a type Ⅱ collagen scaffold to mechanical compression [J]. J Biomed Mater Res,2003, 64(3):560.
[27] 张永涛.不连通双层PLGA支架负载自体骨髓间充质干细胞与富血小板血浆的复合体修复骨软骨缺损的实验研究[D].广州:南方医科大学,2013.
[28] 张旭东,逯卓卉,陈伟,等.用组织工程学方法探讨兔佐剂性关节炎关节软骨修复的实验研究[J].北京生物医学工程,2016,35(2):185-190.
[29] 于洪宇,马春雨.壳聚糖-胶原凝胶复合骨髓间充质干细胞修复兔关节软骨缺损的组织学变化[J].中国组织工程研究,2010,14(25):4581-4584.
[30] 林涛,陈竹,袁德超,等.壳聚糖水凝胶复合脂肪间充质干细胞修复兔关节软骨缺损[J].中华创伤杂志,2016, 32(4):357-362.
[31] 杨自权,何君仁,李刚,等.可塑形脱细胞软骨基质材料的制备及性状研究[J].中国修复重建外科杂志,2008, 22(10):1232-1237.
[32] Augst AD,Kong HJ,Mooney DJ. Alginate hydrogels as biomaterials [J]. Macromol Biosci,2006,6(8):623-633.
[33] Adachi T,Osako Y,Tanaka M,et al. Framework for optimal design of porous scaffold microstructure by computational simulation of bone regeneration [J]. Biomaterials,2006,27(21):3964-3972.
[34] 陈哲峰,范卫民,刘峰.利用PLA、PGA、PLGA三种支架再生兔关节软骨[J].江苏医药,2005,31(8):599-601.
[35] Vacanti CA,Langer R,Schloo B,et al. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation [J]. Plast Reconstr Surg,1991,88(5):753-759.
[36] 刘建斌.壳聚糖-明胶/β-磷酸三钙复合体作为组织工程软骨支架材料的实验研究[J].组织工程与重建外科杂志,2010,6(6):319-322.
[37] Dan K,Prabhakaran MP,Benjamin S,et al. Mechanical properties and,in vitro behavior of nanofiber-hydrogel composites for tissue engineering applications[J]. Nanotechnology,2012,23(9):095705.
[38] Thorpe SD,Buckley CT,Vinardell T,et al. The response of bone marrow-derived mesenchymal stem cells to dynamic compression following TGF-β3 induced chondrogenic differentiation [J]. Ann Biomed Engineering,2010, 38(9):2896-2909.
[39] Bosnakovski D,Mizuno M,Kim G,et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells(MSCs)in different hydrogels:influence of collagen type Ⅱ extracellular matrix on MSC chondrogenesis [J]. Biotechnol Bioengineering,2006,93(6):1152-1163.
[40] 同志超,杨镇,同志勤,等.骨髓间质干细胞体外定向诱导分化为软骨细胞的实验研究[J].中国骨伤,2008,21(5):362-364.
[41] Nixon AJ,Goodrich LR,Scimeca MS,et al. Gene therapy in musculoskeletal repair [J]. Ann New York Acad Sci,2007, 1117(1):310-327.
[42] 付勤,王勇,于冬冬,等.外源性TGF-β1及IGF-1诱导大鼠脂肪干细胞向软骨细胞分化的实验研究[J].中国骨质疏松杂志,2007,13(12):848-853.
[43] Hanada K,Solchaga LA,Caplan AI,et al. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis [J]. J Cell Biochem,2001,81(2):284-294.
[44] Matsumoto T,Kubo S,Meszaros LB,et al. The influence of sex on the chondrogenic potential of muscle-derived stem cells:implications for cartilage regeneration and repair [J]. Arthrit Rheumat,2008,58(12):3809-3819.
[45] Guo XD,Du JY,Zheng QX,et al. Neocartilage formation in vitro using transduced mesenchymal stem cells cultured on biomimetic biodegradable polymer scaffolds [J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2001,23(4):373-377.
[1]
周恒杰 刘思伯 舒姣洁. 连续性血浆滤过吸附对重症急性胰腺炎细胞因子的调节作用 [J]. 中国医药导报, 2019, 16(4): 92-95,99.
[2]
李亚芳 徐岷. 支架蛋白IQGAP3在肿瘤中的作用及研究进展 [J]. 中国医药导报, 2019, 16(14): 23-25,32.
[3]
桂芳1 黄娟1 阳大庆2 刘立亚1. HPV感染对宫颈免疫微环境的影响 [J]. 中国医药导报, 2019, 16(13): 163-166.
[4]
刘璐瑶 刘可可 张雯雯 曹娟 杜奥博 李波. 肿瘤相关巨噬细胞分泌的细胞因子在肿瘤微环境中作用的研究进展 [J]. 中国医药导报, 2019, 16(11): 30-33.
[5]
李小勇1 林建美2. 椎动脉支架成形术和药物治疗椎动脉动脉粥样硬化狭窄的效果比较 [J]. 中国医药导报, 2019, 16(11): 126-129.
[6]
黄梅青1 朱燕华2 赵世元2. 石仙桃多糖对肺炎支原体感染模型小鼠Th1/Th2细胞因子表达的影响 [J]. 中国医药导报, 2018, 15(8): 15-19.
[7]
杨力 吴惠珍 甘海丝. 生长激素对重度宫腔黏连患者的治疗效果及对妊娠结局和炎性细胞因子的影响 [J]. 中国医药导报, 2018, 15(6): 84-87.
[8]
张小佛 王曼知 危松青 李嘉 吴蕾. 喘支炎患儿血清维生素D与细胞因子、免疫球蛋白E及酸性粒细胞阳离子蛋白的关系 [J]. 中国医药导报, 2018, 15(36): 79-82.
[9]
王菁1 解燕昭2 刘云娥1 秦世杰1 朱倩1. 颅内支架置入术治疗颅内动脉粥样硬化性狭窄近远期疗效观察及再狭窄危险因素分析 [J]. 中国医药导报, 2018, 15(35): 110-113.
[10]
刘伟 吴鸿波. 通州地区3~6岁儿童反复呼吸道感染病原菌分布及免疫监测结果分析 [J]. 中国医药导报, 2018, 15(32): 84-87.
[11]
路建荣1 陈喆2 张福全1. 连续性肾脏替代疗法对重症急性肾功能损伤患者的疗效及IL-6和TNF-α的影响 [J]. 中国医药导报, 2018, 15(30): 62-65.
[12]
刘杰 王伟 李刚 覃庆平 周毅 杨剑文 卢启海 姚远. 单根和双重双J管留置对复发性良性输尿管狭窄的疗效比较 [J]. 中国医药导报, 2018, 15(3): 56-59.
[13]
艾月琴1 江龙委2▲ 赵华2 高艳荣2 贾绍昌2. 术后序贯DC-CIK细胞治疗对局部晚期非小细胞肺癌术后生存率及免疫功能的影响 [J]. 中国医药导报, 2018, 15(29): 100-103,107.
[14]
梁颖1 黄汉辉1 赖天幸1 邹端1 林彩燕1 陈晞明2 严鹏科1▲. 紫杉醇药物涂层球囊治疗冠脉支架内再狭窄的临床研究 [J]. 中国医药导报, 2018, 15(26): 43-45.
[15]
代鸣明1 苏庆杰1 于航2 龙发青1 吴映曼1 王德生1 王布飞1 高畅3. 颈动脉支架置入术对不同年龄段的颈动脉狭窄患者血流动力学的影响 [J]. 中国医药导报, 2018, 15(26): 58-61.